Navigation Links
Gift transforms University's approach to fertility research and treatment
Date:7/2/2014

The University of Sydney today announced a major initiative in the field of fertility research and treatment, as it takes over ownership of Westmead IVF Pty Limited, the company which operates the private fertility clinic at Westmead Hospital, Westmead Fertility Centre.

Westmead IVF has been given to the University as part of a major gift from a foundation established by one of the University's own alumni and staff members, Professor of Obstetrics and Gynaecology, Brian Trudinger. The fertility service was established 30 years ago and Professor Trudinger has been custodian for the past 22 years. It has the express aim of making high quality fertility treatment accessible to all patients at the lowest possible cost.

As well as a 100 percent share in Westmead IVF Pty Ltd, the gift includes a $10.4 million cash donation which will establish both a chair in reproductive endocrinology and infertility and endow a research program in maternal foetal medicine. The company will continue to support ongoing world-class research in the field at the University. This would collocate the two phases of reproduction, falling pregnant and carrying a pregnancy to a successful outcome.

The University's Vice-Chancellor, Dr Michael Spence, said this gift represented a unique opportunity to build on Sydney Medical School's existing strength in reproductive, maternal and child health while at the same time providing the best possible clinical services to patients.

"By combining research into the beginnings of life, fertility, conception, the foetus, pregnancy and birth with a clinical facility for reproductive technology services, this gift will enable us to deepen and broaden that research and to return Australia to a position of world leadership in the field of assisted reproductive technologies. This gift is an outstanding example of a donation to the INSPIRED fundraising Campaign and donors' capacity to transform the landscape in a particular area of research.

"What makes this gift particularly appropriate is that the University and Westmead IVF share a commitment to serving the community and to quality and equity of access. It also gives us an opportunity to work even more closely with the Western Sydney Local Health District to advance the health of the community by aligning research and clinical treatment, a model which has been clearly shown to lead to innovation and better health care for patients."

The Dean of Sydney Medical School, Professor Bruce Robinson, expressed his sincere gratitude for the gift, saying, "This gift brings together the link between clinical service, research and teaching for which Sydney Medical School and the University are renowned".

Professor Trudinger sees the University as the natural guardian of a fertility service with core values of quality, accessibility and scientific enquiry.

"The strength of the University in research and academic activity would be a great benefit to the hospital. I am delighted the University has so enthusiastically embraced this venture," he said.

The gift has been welcomed by both the Western Sydney Local Health District (WSLHD) and Westmead Hospital. Emeritus Professor Stephen Leeder, Board Chair of WSLHD, said improved health outcomes resulted from partnerships in a continuum of translational research from the laboratory to the bedside.

"This endowment and gift will enable the University of Sydney and the Western Sydney Local Health District at Westmead Hospital to strengthen their contribution to providing the best possible care at the beginning of life. Professor Trudinger and his colleagues have done superbly in this field and I am confident they will continue to do so through future research and and clinical service," he said.

This is the University's second major new initiative in health research in as many months, following the launch in June of the new Charles Perkins Centre, which aims to ease the burden of obesity, diabetes, cardiovascular disease and related conditions by generating collaborative interdisciplinary research and education that translates into real-world solutions.


'/>"/>

Contact: Verity Leatherdale
verity.leatherdale@sydney.edu.au
61-043-060-7342
University of Sydney
Source:Eurekalert

Related medicine news :

1. Genomic tumor testing to match lung cancer patients with targeted drugs transforms care
2. Cast Covers Brand Transforms Broken Limbs into 3-D Animal Adventures with new CastCritterz! for Children
3. AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub
4. New approach identifies cancer mutations as targets of effective melanoma immunotherapy
5. Taking the random out: New approach to medical studies could boost participation
6. Researchers at the Gladstone Institutes find novel approach to reactivate latent HIV
7. A new approach to Alzheimers disease research
8. BMJ urged to widen its approach to transparency
9. Study finds coordinated approach improves quality of primary care
10. Standard approaches to menopause symptoms discount non-Western experiences
11. Mapping atherosclerotic arteries: Combined approach developed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Texas ... week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. ... The company had 800 customers and 2,250 RCEs at the time of acquisition. ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... clinic serving San Francisco and environs, is proud to announce an upgrade to ... information on the upgraded Yelp page on topics as diverse as Platelet Rich ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design Awards ... of International Social Design Awards. , The 7th A' Social Design Award ... and Institutions worldwide with realized projects and conceptual works. , The first phase ...
(Date:2/26/2017)... York, New York (PRWEB) , ... February 26, ... ... luxury baby products for wholesale distribution in North America, today announced it would ... online sites. The company, which prides itself on crafting quality and unique baby ...
(Date:2/26/2017)... ... 2017 , ... ODH, Inc.™ announced today it will exhibit and speak ... City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will ... Medicaid population health management. , ODH will also have an exhibit booth where attendees ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017 Juan Monteverde ... Associates PC , a boutique securities firm headquartered at ... City , announces that a class action lawsuit ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" ... Company,s securities between July 23, 2015 and December 30, 2016, ...
(Date:2/24/2017)... MELBOURNE , Australien, 24. Februar 2017 /PRNewswire/ ... innovatives, diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für ... Vergleich mit dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen ... BioMedical und Aktualisierung zum Wachstum" finden Sie ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
Breaking Medicine Technology: